Established in 1995, Shree Ganesh Remedies Limited operates as a prominent pharmaceutical intermediate manufacturing company based in India. The company is dedicated to the development of both Basic and Advanced intermediates for Active Pharmaceutical Ingredients (APIs), catering to both the generic and regulated markets.
Expanding its horizons, Shree Ganesh Remedies has recently ventured into the realm of New Chemical Entities (NCE), marking a significant stride in drug development.
With a commitment to excellence, Shree Ganesh Remedies (SGRL) proudly holds ISO certifications including ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. The company specializes in the manufacturing of pharmaceutical intermediates and fine chemicals, boasting a product lineup that encompasses:
- Chloroalkyl Amines Salts
- Friedel Craft’s Derivatives
- Esters and Acid Chlorides
- Anti-psychotic Agents
- Anti-parasitic Compounds
Shree Ganesh Remedies effectively distributes its products across various regions of India, while also extending its reach through exports to international markets. The company’s persistent pursuit of growth and excellence propels it to achieve remarkable heights in the pharmaceutical domain.
Shree Ganesh Remedies Ltd Stock Quote #
- Open: ₹437.05
- High – Low: ₹443.00 – ₹430.05
- Previous Close: ₹441.15
- Total Traded Value: 7,199
- 52 Weeks High: ₹475.35 (Jul 03, 2023)
- 52 Weeks Low: ₹211.71 (Oct 20, 2022)
- Updated On: Aug 11, 2023 4:00 PM
Shree Ganesh Remedies Rights Issue 2023 Detail #
Issue Open | Feb 13, 2023 – Feb 21, 2023 |
Security Name | Shree Ganesh Remedies Limited |
Issue Size (Shares) | 840,471 |
Issue Size (Amount) | ₹18.91 Crores |
Issue Price | ₹225 per share |
Face Value | ₹10 per share |
Listing At | BSE |
Terms of Payment | Rs. 135 per share (60%) on application and remaining Rs. 90 (40%) on subsequent calls. |
Entitlement | 7 Rights Equity Shares for Every 100 Equity Shares held as on the record date |
Shree Ganesh Remedies Rights Issue 2023 Issue Timetable #
Record Date | Feb 3, 2023 |
Credit of Rights Entitlements | Feb 15, 2023 |
Bid/Offer Opens On | Feb 13, 2023 |
Renunciation of Rights Entitlements | Feb 15, 2023 |
Bid/Offer Closes On | Feb 21, 2023 |
Deemed Date of Allotment | Mar 1, 2023 |
Credit Date | Mar 3, 2023 |
Listing Date | Mar 8, 2023 |
Company Financials #
Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
---|---|---|---|---|
31-Mar-21 | 60.6 | 51.18 | 9.75 | 49.44 |
31-Mar-22 | 77.02 | 74.86 | 13.4 | 55.79 |
Amount in ₹ Crore |
Objects of the Issue: #
The Company intends to utilize the Net Proceeds from the Issue towards the funding of the following objects:
- Part repayment or prepayment of unsecured loans availed from the Promoters and from the member of the Promoter Group
- Meeting Working Capital Requirements; and
- General corporate purposes.
Shree Ganesh Remedies Rights Issue 2023 Documents #
ompany Contact Information #
Plot no. 6011,
G.I.D.C,
Ankleshwar – 393002Phone: +91 02646-227777
Email: investors@ganeshremedies.com
Website: http://www.ganeshremedies.com/
Shree Ganesh Remedies Rights Issue 2023 Registrar #
- Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightissue@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html